Scinovex
articleTop 1% cited

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Journal of Clinical Oncology · 2000 · Vol. 18(16) · pp. 2938–2947

Abstract

The LV5FU2-oxaliplatin combination seems beneficial as first-line therapy in advanced colorectal cancer, demonstrating a prolonged progression-free survival with acceptable tolerability and maintenance of QoL.

Colorectal Cancer Treatments and StudiesCancer Treatment and PharmacologyGastric Cancer Management and OutcomesMedicineOxaliplatinFluorouracilBolus (digestion)RegimenNeutropeniaInternal medicineGastroenterologyColorectal cancerPhases of clinical research

MeSH terms

OxaliplatinAdenocarcinomaAdolescentAdultAgedAntineoplastic Combined Chemotherapy ProtocolsLeucovorinDiarrheaFemaleFluorouracilHumansMaleMiddle AgedNeutropeniaOrganoplatinum Compounds
Citations
3,810
FWCI
61.36
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
Cited by
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
International Journal of Molecular Sciences · 2017 · 1,517 citations
References
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
JNCI Journal of the National Cancer Institute · 1959 · 14,848 citations
Regression Models and Life-Tables
Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 38,926 citations
Nonparametric Estimation from Incomplete Observations
Journal of the American Statistical Association · 1958 · 38,793 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.